Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma

Published:2021-06 Issue: Volume:188 Page:114546
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wang Yingying,Zhu Qianying,Hu Haihong,Zhu Hong,Yang Bo,He Qiaojun,Yu Lushan,Zeng Su

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference41 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

2. Chemotherapy for hepatocellular carcinoma: current status and future perspectives;Ikeda;Jpn. J. Clin. Oncol.,2018

3. The different mechanisms of cancer drug resistance: a brief review;Mansoori;Adv. Pharm. Bull.,2017

4. Failure of chemotherapy in hepatocellular carcinoma due to impaired and dysregulated primary liver drug metabolizing enzymes and drug transport proteins: what to do?;Ul-Islam;Curr. Drug Metab.,2018

5. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib;Al-Abdulla;Br. J. Pharmacol.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SND1 Regulates Organic Anion Transporter 2 Protein Expression and Sensitivity of Hepatocellular Carcinoma Cells to 5-Fluorouracil;Drug Metabolism and Disposition;2024-07-03

2. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

3. Progress in Epigenetic Modification Regulating Drug Transporters in the Hypoxic Environment;Current Drug Delivery;2024-06-27

4. HDAC7: a promising target in cancer;Frontiers in Oncology;2024-02-28

5. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions;British Journal of Clinical Pharmacology;2024-01-25